Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Juan Alvarez

Orthopaedic Surgery Sebring, FL Medical Doctor

NPI 1356458707 CMS profile 106441

5115 US Highway 27 N Ste 100, Sebring, FL 33870

Open in the dashboard

General payments

$496,235

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Juan Alvarez of Sebring, FL is reported in the CMS Open Payments database as having received $496,235 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $67,398 25
2024 General $79,232 24
2023 General $79,783 20
2022 General $62,213 15
2021 General $59,794 14
2020 General $67,637 15
2019 General $80,178 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Juan Alvarez
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Juan Alvarez were reported at $67,398. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Juan Alvarez Orthopaedic Surgery median Middle half National median
2019 $80,178 $644 $140–$2,844 $163
2020 $67,637 $312 $75–$1,860 $114
2021 $59,794 $520 $117–$2,495 $132
2022 $62,213 $598 $128–$2,731 $149
2023 $79,783 $461 $128–$2,264 $160
2024 $79,232 $497 $134–$2,475 $164
2025 $67,398 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ortho Development Corporation $494,362 121 payments
  2. Stryker Corporation $1,514 11 payments
  3. Curonix LLC $109 3 payments
  4. Avanos Medical $65 3 payments
  5. Zimmer Biomet Holdings, Inc. $40 1 payment
  6. Bioventus LLC $34 2 payments
  7. Heraeus Medical, LLC. $31 2 payments
  8. Boston Scientific Corporation $28 1 payment
  9. DePuy Synthes Sales Inc. $23 1 payment
  10. Coastal Medical Technologies LLC $15 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $459,479 85 payments
  2. Travel and Lodging $19,138 18 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,000 1 payment
  4. Consulting Fee $2,625 2 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  6. Food and Beverage $1,948 39 payments
  7. Education $45 1 payment
Products named General payments · program years 2019–2025
  1. Entrada Hip Stem $339,235 69 payments
  2. Entrada $123,670 29 payments
  3. MAKO $1,235 7 payments
  4. BKS TriMax $482 6 payments
  5. PANGEA $242 3 payments
  6. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $109 3 payments
  7. Legend $85 1 payment
  8. Trivicta $58 1 payment
  9. COOLIEF* COOLED RADIOFREQUENCY $49 2 payments
  10. Fluid Systems $40 1 payment
  11. Other $258 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

2,437

Median for Orthopedic Surgery: 203

Drug cost

$14,066

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 364 $3,453
Cefadroxil Generic 457 $3,135
Oxycodone Hcl Generic 498 $1,721
Celecoxib Generic 111 $1,596
Doxycycline Hyclate Generic 118 $1,264
Naproxen Generic 156 $1,257
Amoxicillin Generic 447 $617
Gabapentin Generic 48 $225
Duloxetine Hcl Generic 24 $203
Tramadol Hcl Generic 38 $157

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$479,410

Of which drugs: $24,805

Medicare patients

1,268

Average age 76

Services billed

9,167

795 women, 473 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 39%
Diabetes 34%
Chronic kidney disease 31%
Depression 24%
COPD 22%
Atrial fibrillation 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 68 3,601 $19,596
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 302 827 $4,398

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record